Anti-TNFSF5/CD40L/CD154 Antibody (Dapirolizumab)
Catalog No.
F1823
Anti-TNFSF5/CD40L/CD154 Antibody (Dapirolizumab)
Featured Products
Dapirolizumab pegol (CDP 7657) is a monoclonal antibody of the Fab'-IgG-κ class targeting CD40LG/TNFSF5, conjugated to a pegol group. Dapirolizumab pegol was originally cloned from the Norway rat (Rattus norvegicus).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1416147-64-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Dapirolizumab pegol, CDP7657
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P29965
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFSF5 / CD40L / CD154
Please avoid freeze-thaw cycles.